IL18 and neoplasm: These dichotomous effects underscore the complex therapeutic implications of IL-18 in oncology, necessitating further investigation into its context-dependent mechanisms within distinct tumour microenvironments and comprehensive evaluation of its feasibility as a therapeutic target20,21.